Report overview
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report aims to provide a comprehensive presentation of the global market for Cancer Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Drug Therapy. This report contains market size and forecasts of Cancer Drug Therapy in global, including the following market information:
Global Cancer Drug Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Drug Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Drug Therapy companies in 2022 (%)
The global Cancer Drug Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Drug Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Type, 2022 (%)
Targeted Therapy
Chemotherapy
Immunotherapy
Global Cancer Drug Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Application, 2022 (%)
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Global Cancer Drug Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Drug Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Drug Therapy revenues share in global market, 2022 (%)
Key companies Cancer Drug Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Drug Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Drug Therapy, market overview.
Chapter 2: Global Cancer Drug Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Drug Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Drug Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Drug Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
